These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35249786)
1. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma. Yang SW; Lee YC; Lee YS; Chang LC; Lai YR Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786 [TBL] [Abstract][Full Text] [Related]
2. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia. Xia RH; Song XM; Wang XJ; Li J; Mao L PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135 [TBL] [Abstract][Full Text] [Related]
3. Overestimated risk of transformation in oral lichen planus. Cai X; Zhang J; Zhang H; Li T Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493 [TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209 [TBL] [Abstract][Full Text] [Related]
5. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation. Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687 [TBL] [Abstract][Full Text] [Related]
6. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia. Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153 [TBL] [Abstract][Full Text] [Related]
8. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders. Tarle M; Müller D; Raguž M; Lukšić I Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600 [TBL] [Abstract][Full Text] [Related]
9. Prognostic outcomes of oral squamous cell carcinoma derived from proliferative verrucous leukoplakia: A systematic review. Faustino ISP; de Pauli Paglioni M; de Almeida Mariz BAL; Normando AGC; Pérez-de-Oliveira ME; Georgaki M; Nikitakis NG; Vargas PA; Santos-Silva AR; Lopes MA Oral Dis; 2023 May; 29(4):1416-1431. PubMed ID: 35199416 [TBL] [Abstract][Full Text] [Related]
10. Association between hyperglycemia and the malignant transformation of oral leukoplakia in China. Li J; Liu Y; Zhang H; Hua H Oral Dis; 2020 Oct; 26(7):1402-1413. PubMed ID: 32348606 [TBL] [Abstract][Full Text] [Related]
11. Wolf in sheep's clothing - Oral proliferative verrucous leukoplakia: Progression with longitudinal molecular insights. Afkhami M; Maghami E; Gernon TJ; Villaflor V; Bell D Ann Diagn Pathol; 2023 Apr; 63():152104. PubMed ID: 36640643 [TBL] [Abstract][Full Text] [Related]
12. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer. Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723 [TBL] [Abstract][Full Text] [Related]
13. EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation. Ganesh D; Dafar A; Niklasson J; Sandberg I; Braz-Silva P; Sapkota D; Öhman J; Giglio D; Hasséus B Anticancer Res; 2023 Apr; 43(4):1533-1542. PubMed ID: 36974822 [TBL] [Abstract][Full Text] [Related]
14. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study. von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919 [TBL] [Abstract][Full Text] [Related]
15. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers. Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa. Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189 [TBL] [Abstract][Full Text] [Related]
17. Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation. Yang SW; Lee YS; Chang LC; Yang CH; Luo CM; Wu PW Clin Oral Investig; 2021 Jun; 25(6):4045-4058. PubMed ID: 33411001 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study. Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769 [TBL] [Abstract][Full Text] [Related]
20. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway. Liu W; Yao Y; Shi L; Tang G; Wu L J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]